$FATE FATE THERAPEUTICS INC Insider Trading
Get free email notifications about insider trading in FATE THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in FATE THERAPEUTICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in FATE THERAPEUTICS INC for free.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: FATE
Company Address: 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO 92121
Phone number: 858.875.1800
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.
Market Capitalization: $95.27M
Prev close: $2.80
Average Daily Volume: 153,960
Days Low: $2.78
Year Low: $1.46
Year High: $3.82
FATE THERAPEUTICS INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2021 | FATE | FATE THERAPEUTICS ... | Jooss Karin | Director | Option Exercise | A | 68.94 | 4,334 | 298,786 | 4,334 | |
| Jun 04 2021 | FATE | FATE THERAPEUTICS ... | Jooss Karin | Director | Grant | A | 0.00 | 2,681 | 0 | 2,681 | 0 to 2.7 K |
| Jun 04 2021 | FATE | FATE THERAPEUTICS ... | RASTETTER WILLIAM H | Director | Option Exercise | A | 68.94 | 4,334 | 298,786 | 4,334 | |
| Jun 04 2021 | FATE | FATE THERAPEUTICS ... | RASTETTER WILLIAM H | Director | Grant | A | 0.00 | 2,681 | 0 | 2,681 | 0 to 2.7 K |
| May 24 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Option Exercise | M | 4.84 | 20,000 | 96,700 | 44,846 | |
| May 24 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Sell | S | 77.16 | 20,000 | 1,543,292 | 393,793 | 413.8 K to 393.8 K (-4.83 %) |
| May 24 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Buy | M | 4.84 | 20,000 | 96,700 | 413,793 | 393.8 K to 413.8 K (+5.08 %) |
| Apr 26 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Option Exercise | M | 4.84 | 5,154 | 24,920 | 64,846 | |
| Apr 26 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Option Exercise | M | 6.62 | 14,846 | 98,281 | 0 | |
| Apr 26 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Option Exercise | M | 2.73 | 10,000 | 27,300 | 130,000 | |
| Apr 26 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Option Exercise | M | 2.73 | 30,000 | 81,900 | 140,000 | |
| Apr 26 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Sell | S | 85.24 | 30,000 | 2,557,284 | 393,793 | 423.8 K to 393.8 K (-7.08 %) |
| Apr 26 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Buy | M | 4.84 | 5,154 | 24,920 | 423,793 | 418.6 K to 423.8 K (+1.23 %) |
| Apr 26 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Buy | M | 6.62 | 14,846 | 98,281 | 418,639 | 403.8 K to 418.6 K (+3.68 %) |
| Apr 26 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Buy | M | 2.73 | 10,000 | 27,300 | 403,793 | 393.8 K to 403.8 K (+2.54 %) |